Lupin gets US FDA nod for Doxycycline Hyclate Delayed-Release Tablets USP

Lupin Limited announced that it has received FDA approval for its Abbreviated New Drug Application for doxycycline hyclate delayed-release tablets USP, 50 mg, 60 mg, 75 mg, 80 mg, 100 mg, 120 mg, 150 mg, and 200 mg, to market a generic equivalent...

Exor Acquires a 15% Stake in Philips for Approximately $2.8 Billion

Philips announced earlier this week that Dutch investment firm Exor NV has acquired a 15% stake in the company for approximately 2.6 billion euros ($2.84 billion)...

AIIMS Delhi inks MoU with GGSIP University to Revolutionise Patient Care

AIIMS Delhi and Guru Gobind Singh Indraprastha University (GGSIPU) have announced a strategic collaboration aimed at revolutionizing patient care through the implementation of a patient grievance redressal system.

Parliamentary Panel asks Govt to Execute Mental Healthcare Act and Monitor Insurance Delivery

A Parliamentary Panel that investigated the country's mental healthcare and management policies found that, despite the fact that the Mental Healthcare Act (MHCA), 2017 was introduced five years ago, there is still much work...

How Gene Editing Technologies are Transforming Pharma

Gene editing technologies, particularly CRISPR-Cas9, are redefining the pharmaceutical industry by facilitating scientists to manipulate the genetic code with unprecedented precision

Monoclonal Antibodies: Revolutionizing Drug Discovery and Development

Ground-breaking discoveries in the field of modern medicine frequently result from creative strategies for medication development and research.

India Should Work with Canadian pharmaceutical Regulatory Agencies to Encourage Investment in the country, say Experts

According to trade specialists, the Indian government wants Canadian regulatory agencies to recognise and commercialise pharmaceutical items in order to incentivize investment opportunities...

Fortis Gurugram Introduces State-of-the-art PET CT Machine for Advanced imaging in Cancer Diagnosis

Fortis Cancer Institute, Fortis Memorial Research Institute, Gurugram has launched a first-in-India advanced and cutting-edge Digital PET CT machine for advanced imaging, with the goal of improving cancer diagnosis and revolutionizing...

Zydus Lifesciences India More than Doubles Profit Due to Increased Sales in the US

Zydus Lifesciences Ltd, an Indian generic drugmaker, announced later this week that its profit more than doubled in the first quarter, owing to strong sales in its US market...

Healthtech Start-up Suraksha QR Ropes In Actor Murali Sharma as its Brand Ambassador

Hyderabad-headquartered healthcare-technology start-up Suraksha QR has announced the appointment of veteran actor Murali Sharma as its brand ambassador. Following this, the actor will be representing the emerging Suraksha QR brand....

on the deck


Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.